title: F2-isoprostanes are not just markers of oxidative stress.
abstract: F(2)-isoprostanes are not just markers of oxidative stress. The discovery of F(2)-isoprostanes (F(2)-IsoPs) as specific and reliable markers of oxidative stress in vivo is briefly summarized here. F(2)-IsoPs are also agonists of important biological effects, such as the vasoconstriction of renal glomerular arterioles, the retinal vessel, and the brain microcirculature. In addition to the F(2)-IsoPs, E(2)- and D(2)-IsoPs can be formed by rearrangement of H(2)-IsoP endoperoxides and can give rise to cyclopentenone IsoPs, which are very reactive alpha,beta-unsaturated aldehydes. The same type of reactivity is also shown by acyclic gamma-ketoaldehydes formed as products of the IsoP pathway. Because previous studies suggested a relation between oxidative stress and collagen hyperproduction, it was investigated whether collagen synthesis is induced by F(2)-IsoPs, the most proximal products of lipid peroxidation. In contrast to aldehydes, F(2)-IsoPs act through receptors able to elicit definite signal transduction pathways. In a rat model of carbon tetrachloride-induced hepatic fibrosis, plasma F(2)-IsoPs were markedly elevated for the entire experimental period; hepatic collagen content was also increased. When hepatic stellate cells from normal liver were cultured up to activation (expression of smooth muscle alpha-actin) and then treated with F(2)-IsoPs in the concentration range found in the in vivo studies (10(-9) to 10(-8) M), a striking increase in DNA synthesis, cell proliferation, and collagen synthesis was observed. Total collagen content was similarly increased. All these stimulatory effects were reversed by the specific antagonist of the thromboxane A(2) receptor, SQ 29 548, whereas the receptor agonist, I-BOP, also had a stimulatory effect. Therefore F(2)-IsoPs generated by lipid peroxidation in hepatocytes may mediate hepatic stellate cell proliferation and collagen hyperproduction seen in hepatic fibrosis.
authors.affiliation: Department of Pathophysiology, Experimental Medicine, and Public Health, University of Siena, 53100 Siena, Italy. comporti@unisi.it
authors.forename: Mario
authors.initials: M
authors.lastname: Comporti
authors.forename: Cinzia
authors.initials: C
authors.lastname: Signorini
authors.forename: Beatrice
authors.initials: B
authors.lastname: Arezzini
authors.forename: Daniela
authors.initials: D
authors.lastname: Vecchio
authors.forename: Barbara
authors.initials: B
authors.lastname: Monaco
authors.forename: Concetta
authors.initials: C
authors.lastname: Gardi
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000737:chemistry / Q000378:metabolism; D003094:Collagen / Q000378:metabolism; D028441:F2-Isoprostanes / Q000737:chemistry* / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D015227:Lipid Peroxidation; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008103:Liver Cirrhosis / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D018384:Oxidative Stress; D011658:Pulmonary Fibrosis / Q000209:etiology; D051381:Rats; D011982:Receptors, Prostaglandin / Q000378:metabolism
chemical_list: D015415:Biomarkers; D028441:F2-Isoprostanes; D011982:Receptors, Prostaglandin; C034671:prostaglandin F2alpha receptor; D003094:Collagen